In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Mehr ...Neue Daten zum Überleben von Brustkrebspatientinnen mit Chemotherapie während der Schwangerschaft
Mehr ...We are happy to present our research at the ASCO Annual meeting June 2022.
Mehr ...GBG research at ESMO Breast Cancer Meeting 2022 May 3rd to 5th in Berlin.
Mehr ...GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd